Satellos Announces Encouraging Functional Data from the 28-day Phase 1b Open-Label Trial of SAT-3247 in Adults with Duchenne Muscular Dystrophy
Stock Information for Athabasca Minerals Inc.
Loading
Please wait while we load your information from QuoteMedia.